✦ LIBER ✦

Clinical experience with a new long-acting neuromuscular blocking agent

✍ Scribed by Fawzy G. Estafanous

Publisher: Elsevier Science
Year: 1990
Tongue: English
Weight: 160 KB
Volume: 4
Category: Article
ISSN: 0888-6296
DOI: 10.1016/0888-6296(90)90512-e

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical pharmacology of ORG 7617, a sho

Clinical pharmacology of ORG 7617, a short-acting non-depolarizing neuromuscular blocking agent

✍ L. Broek; J. M. K. H. Wierda; J. H. Proost; F. D. M. Hommes; S. Agoston 📂 Article 📅 1994 🏛 Springer 🌐 English ⚖ 475 KB

The dose-response relationship and the time course of action of Org 7617, a short acting non-depolarizing neuromuscular blocking agent, were evaluated during thiopentone, fentanyl, halothane and N20 anaesthesia. Neuromuscular transmission was monitored mechanomyographically. The EDs0 and EDg0 were c

The pharmacodynamics and pharmacokinetic

The pharmacodynamics and pharmacokinetics of Org 9426, a new non-depolarizing neuromuscular blocking agent, in patients anaesthetized with nitrous oxide, halothane and fentanyl

✍ J. Mark K. H. Wierda; Ursula W. Kleef; Ludwina M. Lambalk; Wybe D. Kloppenburg; 📂 Article 📅 1991 🏛 Springer-Verlag 🌐 French ⚖ 442 KB

Clinical experience with N-hexamethylene

Clinical experience with N-hexamethylene N′N″-diethylene thiophosphoramide (KC-33), a new agent for breast and ovarian carcinoma

✍ Louis E. Goodman; Daniel Bakal; Kwan-Chung Tsou; Stanley P. Kramer; Adolph Ulfoh 📂 Article 📅 1965 🏛 John Wiley and Sons 🌐 English ⚖ 560 KB